Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness
- PMID: 23376977
- DOI: 10.1093/europace/eus399
Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness
Abstract
Aims: In several clinical and pre-clinical studies, application of ranolazine (RAN) led to suppression of atrial fibrillation (AF). The aim of the present study was to investigate whether RAN can suppress AF in an experimental rabbit whole heart model, in which acute haemodynamic changes trigger AF. Ranolazine was compared with flecainide and sotalol as established antiarrhythmic agents.
Methods and results: In 60 Langendorff-perfused, isolated rabbit hearts, AF episodes were evoked by burst pacing with a fixed number of stimuli at baseline and following acute atrial stretch. Data were obtained in the absence and presence of acute dilatation of the left atrium (20 mmHg) at baseline and after drug application (RAN 10 µM, n = 10; flecainide 2 µM, n = 10; sotalol 50 µM, n = 10). Application of sotalol, but not RAN or flecainide increased the atrial action potential duration at 90% repolarization (aAPD90); however, both RAN (+8 ms) and flecainide (+13 ms) increased interatrial conduction time. All three drugs caused a significant increase in atrial effective refractory period (aERP) and, thus, an increase in atrial post-repolarization refractoriness (aPRR: +11 ms each, P < 0.05). Acute dilatation of the left atrium reduced aAPD90 and aERP. The described drug effects were preserved in the setting of acute atrial dilatation. Acute atrial dilatation significantly increased the incidence of AF. Ranolazine and flecainide, but not sotalol, decreased the number of responses.
Conclusion: Ranolazine-related sodium channel block is preserved upon acute atrial stretch. Ranolazine suppresses stretch-induced AF by increasing interatrial conduction time and aPRR. These results shed further evidence on the potential role of RAN in the prevention of AF. This might also apply to clinical conditions that are associated with haemodynamic or mechanical disorders, leading to acute dilatation of the atria.
Similar articles
-
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.Cardiovasc Ther. 2013 Dec;31(6):e63-71. doi: 10.1111/1755-5922.12035. Cardiovasc Ther. 2013. PMID: 23647657
-
Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.Eur J Heart Fail. 2012 Dec;14(12):1322-31. doi: 10.1093/eurjhf/hfs163. Epub 2012 Oct 25. Eur J Heart Fail. 2012. PMID: 23099358
-
Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.Basic Res Cardiol. 2005 Mar;100(2):112-21. doi: 10.1007/s00395-005-0513-4. Epub 2005 Feb 9. Basic Res Cardiol. 2005. PMID: 15696400 Clinical Trial.
-
Antiarrhythmic properties of ranolazine: A review of the current evidence.Int J Cardiol. 2015;187:66-74. doi: 10.1016/j.ijcard.2015.03.324. Epub 2015 Mar 21. Int J Cardiol. 2015. PMID: 25828315 Review.
-
Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.Rev Cardiovasc Med. 2009;10 Suppl 1:S46-52. Rev Cardiovasc Med. 2009. PMID: 19898288 Review.
Cited by
-
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model.Naunyn Schmiedebergs Arch Pharmacol. 2017 Nov;390(11):1155-1161. doi: 10.1007/s00210-017-1415-y. Epub 2017 Aug 6. Naunyn Schmiedebergs Arch Pharmacol. 2017. PMID: 28780600
-
Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study.Am J Physiol Heart Circ Physiol. 2023 Nov 1;325(5):H952-H964. doi: 10.1152/ajpheart.00227.2023. Epub 2023 Sep 1. Am J Physiol Heart Circ Physiol. 2023. PMID: 37656133 Free PMC article.
-
Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial.Europace. 2024 Jun 3;26(6):euae121. doi: 10.1093/europace/euae121. Europace. 2024. PMID: 38702961 Free PMC article. Clinical Trial.
-
Effects of Ranolazine and its Combination with Amiodarone on Rapid Pacing-induced Reentrant Atrial Tachycardia in Rabbits.J Innov Card Rhythm Manag. 2021 Mar 15;12(3):4421-4427. doi: 10.19102/icrm.2021.120304. eCollection 2021 Mar. J Innov Card Rhythm Manag. 2021. PMID: 33777481 Free PMC article.
-
25 years of basic and translational science in EP Europace: novel insights into arrhythmia mechanisms and therapeutic strategies.Europace. 2023 Aug 25;25(8):euad210. doi: 10.1093/europace/euad210. Europace. 2023. PMID: 37622575 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous